Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Income from Continuing Operations (2018 - 2023)

Historic Income from Continuing Operations for ImmunoTech (AIM) over the last 6 years, with Q4 2023 value amounting to -$14.0 million.

  • ImmunoTech's Income from Continuing Operations changed N/A to -$14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$29.1 million, marking a year-over-year change of. This contributed to the annual value of -$20.4 million for FY2024, which is 3621.69% up from last year.
  • As of Q4 2023, ImmunoTech's Income from Continuing Operations stood at -$14.0 million.
  • In the past 5 years, ImmunoTech's Income from Continuing Operations ranged from a high of -$3.3 million in Q3 2020 and a low of -$14.0 million during Q4 2023